Patient recruitment starts in phase III study of Ameluz plus BF-RhodoLED in superficial BCC Sep. 27, 2018
Aldeyra announces positive data from phase IIb study of reproxalap topical ophthalmic solution Sep. 27, 2018
Vaccibody presents positive 6-month interim results from phase I/IIa study of VB10.16 immunotherapy Sep. 27, 2018
AI-powered platform for optimization of drug combination regimen in metastatic prostate cancer Sep. 27, 2018
Sareum selects small-molecule inhibitor of TYK2/JAK1 for development for certain cancers Sep. 27, 2018
RSS